Skip to content
Cannabinoid Education: Needs Assessment
1.
What type of health care professional are you:
Primary Care/ GP/ FP
Specialist
Nurse / NP
Pharmacist
Other (please specify)
2.
What is your specialty:
Anatomical pathology
Anesthesiology
Cardiac surgery
Community medicine
Dermatology
Diagnostic radiology
Emergency medicine
General pathology
General surgery
Hematological pathology
Internal medicine
Medical biochemistry
Medical genetics
Medical microbiology
Neurology
Neuropathology
Neurosurgery
Nuclear medicine
Obstetrics and Gynaecology
Occupational Medicine
Ophthalmology
Orthopedic Surgery
Otolaryngology
Pain
Pediatrics
Physical medicine & rehabilitation
Plastic Surgery
Primary care
Psychiatry
Radiation Oncology
Urology
Other (please specify)
3.
How many years have you been providing health care:
0-5
6-10
11-20
20+
4.
Please select the Province you practice in:
Alberta
British Colombia
Manitoba
New Brunswick
Newfoundland
Northwest Territories
Nova Scotia
Nunavut
Ontario
Prince Edward Island
Quebec
Saskatchewan
Yukon
5.
Please rank your current and desired knowledge/skill level for the following topics:
Current knowledge
Desired knowledge
Understanding of the endocannabinoid system
0 (none)
1
2
3
4
5 (high)
0 (none)
1
2
3
4
5 (high)
Understanding of existing cannabinoid medications
0 (none)
1
2
3
4
5 (high)
0 (none)
1
2
3
4
5 (high)
Prescribing cannabinoids effectively
0 (none)
1
2
3
4
5 (high)
0 (none)
1
2
3
4
5 (high)
Understanding of medical marijuana regulations
0 (none)
1
2
3
4
5 (high)
0 (none)
1
2
3
4
5 (high)
Awareness of long term risks of cannabinoids
0 (none)
1
2
3
4
5 (high)
0 (none)
1
2
3
4
5 (high)
6.
Which cannabinoid(s) have you prescribed:
Marinol® (dronabinol)
Cesamet® (nabilone)
Sativex® (THC:CBD)
Medical marijuana
None
7.
For what condition(s) have you prescribed cannabinoids:
Nausea and vomiting
Anoriexia with weight loss
Pain
Spasticity
Sleep
Anxiety
Not applicable
Other (please specify)
8.
In your opinion, what are the main limitations of current cannabinoid therapies: (check all that apply)
Interactions with other medications
Legal issues
Limited evidence
Mechanism of action
Narrow therapeutic window
Need for monitoring
Not a mainstream therapy
Risks
Stigma associated with cannabinoids
Other (please specify)
9.
What factors would increase your comfort level with prescribing cannabinoids: (check all that apply)
Clinical data and supportive studies
Educational programs for physicians
Endorsed guidelines/algorithims including cannabinoids
Long-term safety data
Long-term data evaluating addictive properties
New indications
Patient education information
Peer discussions
Other (please specify)
10.
What are your educational needs for use of cannabinoids in clinical practice: (check all that apply)
Screening /Patient Selection
Prescribing /Dosing
Monitoring
Interactions with other medications
Costs /Coverage
Legal issues /Regulations
Other (please specify)
11.
What format/structure do you prefer for your own learning: (check all that apply)
Academic conferences
Expert speaker tours
Grand rounds
Literature reviews
Mentorship (preceptorship) program
Newsletters
Online learning programs
Small-group learning sessions
Symposia
Workshop
Other (please specify)
12.
Additional feedback: